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The interaction of Epstein– Barr virus (EBV) with epithelial cells and the consequent role of the virus in the aetiology of
undifferentiated nasopharyngeal carcinoma (NPC) is poorly understood. One important obstacle to work in this area has
been the lack of an epithelial cell culture system in which EBV is stably maintained. Using a previously described approach
in which CR2-transfected epithelial cells (SVK-CR2) are rendered susceptible to transient EBV infection (Li et al., Nature
356, 347, 1992), we now demonstrate that the pattern of EBV latent gene transcription in these acutely infected epithelial
cells differs from that observed in virus-infected primary B cells. In addition, some of these epithelial cells spontaneously
entered the EBV lytic cycle. By cloning Akata virus-infected SVK-CR2 cells we generated two stable lines which remained
EBV positive for more than 1.5 years at which time further subclones were isolated. These cloned lines carry the EBV
genome as an episome and exclusively use the FQp promoter for driving EBNA1 transcription, display no Cp/Wp promoter
activity, and express low levels of the LMP mRNAs. Unlike acutely infected SVK-CR2 cells, the cloned lines responded
poorly to suspension-induced terminal differentiation and were impaired in their ability to enter the virus lytic cycle. These
results, showing similarities between the cloned EBV-positive SVK-CR2 lines and NPC tumour cells, suggest that stable
maintenance of EBV in epithelial cells may require an undifferentiated cellular environment. q 1996 Academic Press, Inc.
INTRODUCTION EBV-driven in a manner analogous to that of the lymph-
oblastoid cell lines (LCLs) which arise when EBV infects
Epstein – Barr virus (EBV), a ubiquitous human herpes-
normal resting B cells in vitro; thus the tumour cells show
virus with oncogenic potential, is predominantly associ- an LCL-like pattern of virus latent gene expression en-
ated with infection of two target tissues in vivo: B lympho- compassing six nuclear antigens (EBNAs 1, 2, 3A, 3B,
cytes where the infection is largely nonproductive and 3C, and -LP) and three latent membrane proteins (LMPs
stratified squamous epithelium in which virus replication 1, 2A, and 2B) (Young et al., 1989; Thomas et al., 1991).
occurs (Miller, 1990). Both target tissues are susceptible It is known from studies on LCLs that the different EBNAs
to EBV-associated malignant change, leading to tumours are encoded by individual mRNAs generated by differen-
of B cell origin such as Burkitt’s lymphoma (BL) and im- tial splicing of the same long primary transcripts ex-
munoblastic lymphoma (IBL) or of epithelial cell origin pressed from either the BamHI C promoter (Cp) or the
such as nasopharyngeal carcinoma (NPC) and gastric BamHI W promoter (Wp) (Speck and Strominger, 1989),
adenocarcinomas (Thomas et al., 1991; Raab-Traub, whilst the LMP transcripts are expressed from separate
1992; Shibata and Weiss, 1992; Magrath et al., 1993). promoters in the BamHI N region of the EBV genome
These virus-associated tumours carry the EBV genome (Laux et al., 1989; Speck and Strominger, 1989). The situ-
in episomal form in the malignant cells and are positive ation is different in BL, where EBV forms part of a com-
for EBERs, small noncoding nuclear viral RNAs now rec- plex multistep pathogenesis and where virus latent gene
ognised as the most consistent indicator of latent EBV expression is restricted to EBNA1 only with no transcrip-
infection (Howe and Steitz, 1986; Raab-Traub and Flynn, tion of the Cp, Wp, and the LMP promoters (Rowe et al.,
1986; Gilligan et al., 1990a; Niedobitek et al., 1992; Young 1987b; Young and Rowe, 1992). Recent work has shown
and Rowe, 1992). However, the contribution made by the that the selective expression of EBNA1 results from a
virus to tumour development appears to be different in uniquely spliced mRNA originating from a novel promoter
each of these situations, and this is to some extent re- in the BamHI F/Q region of the viral genome. The tran-
flected in the different patterns of viral gene expression scription initiation site was originally identified as Fp but
observed in the tumour cells. In immunoblastic B cell more precise mapping suggests that the true latent cycle
lymphomas, tumour cell growth appears to be directly start sites lie 100 – 200 bp downstream in BamHI Q, for
the purposes of the present study this promoter will be
referred to FQp (Sample et al., 1991; Schaeffer et al.,1,2 Both authors contributed equally to the study.
1991; Nonkwelo et al., 1995). Yet a third form of latency3 To whom correspondence and reprint requests should be ad-
dressed. Fax: 21 414 4486. E-mail: L.S.Young@bham.ac.uk. is displayed by NPC cells, where FQp-driven EBNA1 tran-
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scripts are detected (again leading to expression of cells and present data on the pattern of EBV gene expres-
sion and differentiation status of these clones.EBNA1 in the absence of other EBNAs) as well as most
or all the LMP mRNAs (Fa˚hraeus et al., 1988; Young et
al., 1988; Brooks et al., 1992). In addition, a series of MATERIALS AND METHODS
spliced rightward-running BamHI A transcripts which
Cell culturesmay encode other, as yet poorly characterised, latent
proteins were originally identified in NPC but have re- The SVK-CR2 and the control SVK-neo cell lines were
cently been shown to be associated with all forms of established as previously described (Li et al., 1992) and
EBV latency (Hitt et al., 1989; Gilligan et al., 1990b; Brooks maintained in normal growth medium (NGM: Joklik me-
et al., 1993). The form of EBV latency observed in NPC, dium containing 10% fetal calf serum, 2 mM glutamine,
where the virus appears to encode some but not all 0.4 mg/ml hydrocortisone, 10 ng/ml cholera toxin, and
of its growth transformation-associated proteins, is also 400 mg/ml G418). For infection with EBV, monolayer cul-
observed in EBV-positive cases of Hodgkin’s disease tures at 70– 80% confluence were washed twice in PBS
(HD) (Deacon et al., 1993). and incubated with EBV (filtered supernatant from either
Whilst the precise contribution of EBV to the malignant induced Akata or AG876 cell cultures) for 4 hr at 377,
conversion of normal nasopharyngeal epithelium is ob- then fed again with NGM. Cultures were refed with fresh
scure, the undifferentiated nature of NPC has been inter- medium every 2– 3 days. After 5 days the cells were
preted as indicating that viral infection of undifferentiated collected by trypsinisation, washed in PBS, and either
cells in the basal layer of stratified squamous epithelium snap-frozen as cell pellets for subsequent RNA or protein
is a prerequisite for the development of this malignancy. extraction or spread on slides as cell smears/cytospins
This raises the possibility that EBV normally persists in for immunofluorescence staining. Control cell lines of
the basal compartment of pharyngeal epithelium and that known EBV status were used as controls in these experi-
oropharyngeal shedding of infectious virus occurs as la- ments and included the EBV-producer LCL B95.8, the
tently infected cells leave the basal compartment enter- EBV-positive Akata BL cell line, and LCLs generated with
ing the lytic virus cycle as a result of squamous epithelial virus obtained from the Akata BL cell line. The EBV-nega-
differentiation (Rickinson et al., 1985; Allday and Craw- tive BL cell lines, BL40, and Louckes were used as nega-
ford, 1988). However, the concept that EBV persistence tive controls.
is dependent on an epithelial reservoir has been coun-
tered by two recent observations: (i) that EBV infection Immunoblotting
can be eradicated by the schedule of whole body irradia-
Protein samples from Akata virus-infected SVK-CR2tion used in bone marrow transplant recipients to destroy
cells, appropriate controls and LCLs were separated byhemopoietic tissue (Gratama et al., 1988) and (ii) the
discontinuous polyacrylamide gel electrophoresis, blot-inability to detect EBV latency in the basal epithelial cells
ted onto nitrocellulose membranes as previously de-of oral hairy leukoplakia (Niedobitek et al., 1991), a lesion
scribed (Young et al., 1988) and probed with a pool offound in AIDS patients associated within rampant virus
three human sera (PB, AMo, RS22) containing antibodiesreplication in the differentiated layers of tongue epithe-
against EBNAs 1, 2, 3A, 3B, and 3C as well as antibodieslium (Greenspan et al., 1985). These data are consistent
against lytic cycle antigens (Li et al., 1992).with normal epithelial tissues sustaining purely lytic EBV
infections, implying that the establishment of EBV latency Immunostaining
in less differentiated epithelial cells is a rare event which
predisposes to the development of NPC (Niedobitek and Slides of cell smears were fixed and stained for EBNA1
by anticomplement immunofluorescence using a mono-Young, 1994).
Studies of the interaction of EBV with epithelial cells specific human serum AMo (Reedman and Klein, 1973).
Immunostaining for EBNA2, LMP1, and BZLF1 was per-have been hampered by difficulties in establishing repre-
sentative NPC cell lines in vitro and by the inability of formed by indirect immunofluorescence using the PE2,
CS1-4, and BZ1 monoclonal antibodies, respectivelyEBV to directly infect normal epithelial cells in culture.
Thus, we sought to examine the establishment of EBV (Rowe et al., 1987a; Young et al., 1989, 1991). Briefly, cell
smears were fixed in cold methanol and stored at 0707latency in epithelial cells using a previously described
culture system in which EBV receptor (CR2)-transfected prior to use. After rehydration in phosphate-buffered sa-
line (PBS) for 5 min, diluted primary antibodies were ap-human epithelial cells (SVK-CR2) are susceptible to EBV
infection (Li et al., 1992). In the original studies with this plied to the sections and the slides incubated at 377 for
60 min. The slides were then subjected to two 15-minsystem we found that the high level of EBV infection
observed immediately after infection was not stable but washes in PBS, followed by an additional 60-min incuba-
tion with a 1/50 dilution of FITC-conjugated goat anti-decreased such that only 10% of the cells remained
EBNA1 positive at 24 days postinfection. In this study we mouse IgG (Sigma). After subsequent washing, slides
were mounted in DABCO solution: 90% glycerol, 10%describe the isolation of cloned EBV-infected SVK-CR2
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PBS, and 2.5% w/v (1,4-diazabicyclo[2,2,2]octane), pH 8.6, Essentially, the samples were heated for 2 min at 907
and rapidly cooled on ice, reverse transcription – PCRand examined using an Olympus UV– fluorescence mi-
(RT – PCR) was performed in a one tube reaction for 60croscope.
min at 427, the samples were heated to 947 for 7 min and
Lytic cycle induction and suspension-induced cooled to 707, and Taq DNA polymerase was added.
differentiation Samples were subjected to 40 rounds of amplification in
a DNA thermal cycler (Perkin– Elmer Cetus). Amplifica-
For EBV lytic cycle induction, SVK-CR2 cells were in- tion conditions were as follows: denaturation 30 sec at
fected with Akata virus and at 5 days postinfection were 947, primer annealing 90 sec at 457; and 240 sec at 707.
refed and exposed to 5 1 1008 M 12-O-tetradecanoyl- For the specific amplification of LMP 1 mRNAs, a higher
phorbol-13-acetate (TPA). The stable SVK-CR2/Akata annealing temperature of 507 and an extension tempera-
clones were refed and exposed to 5 1 1008 M TPA. After ture of 727 for 120 sec were used. The sequences and
48 hr the cells were harvested as above for immunofluo- coordinates of EBV – PCR primers utilised in this study
rescence staining with the BZLF1-specific BZ1 mono- are as previously described (Brooks et al., 1992; Kerr et
clonal antibody (Young et al., 1991). For differentiation al., 1992; Deacon et al., 1993) and are based on the
induction, cells were removed from dishes by trypsinisa- published B95.8 genomic sequence (Baer et al., 1984).
tion and were resuspended as 104 cells in 10 ml of DME Amplified samples were analysed by electrophoresis
medium containing 10% FCS and 2 mM glutamine. The through 3% Nusieve agarose gels and then by Southern
cells were then plated out onto 9-cm bacteriological petri transfer onto Hybond N/ nylon membranes (Amersham).
dishes (Sterilin) that had been pretreated with Sigmacote Detection of amplified products was achieved by hybridi-
(Sigma). After 24 – 48 hr in suspension, cells were recov- sation to end-labelled oligonucleotide probes, the se-
ered by centrifugation and washed extensively in PBS, quences of which are as previously described (4, 7, 20).
and cell smears were made for immunostaining. Cell Oligonucleotide probes were hybridised at 427 overnight
smears were fixed according to the method of Adams in the presence of 51 SSC (11 SSC is 0.1 M NaCl plus
and Watt (1989). Briefly, cells were fixed in 3.7% formalde- 0.015 M sodium citrate), 51 Denhardt solution, 0.5% so-
hyde for 30 min followed by postfixation in ice-cold meth- dium dodecyl sulphate and 100 mg of calf thymus per
anol for 5 min. Cell smears were immunostained using a milliliter in 50% formamide.
1:1000 dilution of the involucrin-specific polyclonal rabbit
Analysis of EBV genome conformationantisera, DH1 (Dover and Watt, 1987) followed by a 1/50
The form of the EBV genome present in EBV-infecteddilution of FITC-conjugated goat anti-rabbit IgG (Sigma)
cells was determined by the Gardella gel techniqueand viewed as described above.
(Gardella et al., 1984) using a nick-translated BHRF1
probe.Amplification and analysis of mRNA transcripts by
PCR RESULTS
EBV gene transcription in acutely infected SVK-CR2RNA was extracted from the relevant cell lines using
cellsthe RNAzol B method according to the manufacturer’s
protocol (Cinna/Biotecx). RNA samples were treated and EBV-infected SVK-CR2 cells were harvested 5 days
postinfection, a time at which maximum levels of EBNA1analysed as described previously (Brooks et al., 1992).
FIG. 1. EBNA1 expression and transcription in acutely infected SVK-CR2 cells. (A) EBNA1 expression in Akata-infected SVK-CR2 cells at 5 days
postinfection. Cell smears were fixed and stained for EBNA1 by anticomplement immunofluorescence (ACIF) using a monospecific human serum,
AMo. Control uninfected SVK-CR2 cells stained negative using the AMo antiserum and no staining was observed when the infected cells were
analysed using antiserum from an EBV-negative donor. (B) PCR analysis of EBNA1 mRNAs in acutely infected SVK-CR2 cells. SVK-CR2 cells infected
with either the Akata or AG876 EBV strain were harvested 5 days postinfection, a time at which maximum levels of EBNA1 expression are observed
as previously described (Li et al., 1992). The B95.8 LCL was used as a positive control for both Q/U/K and Y3/U/K amplification and the uninfected
SVK-CR2 cell line, mock-infected SVK-neo cells, and the EBV-negative Louckes BL cell line were used as negative controls. RNA prepared from
these cells was analysed by reverse transcription– PCR (RT –PCR) for EBNA1 transcribed from either (a) the FQp using a 3* primer (b) within the
BamHI K EBNA1 ORF (shaded) in combination with a 5* primer (c) from the BamHI Q exon (top) or (b) the Cp/Wp using the same 3* primer in
combination with a 5* primer from the BamHI Y3 exon (bottom). Amplified products were detected by Southern blotting with an oligonucleotide
probe (j) from the common BamHI U exon.
FIG. 4. EBNA1 expression and transcription in the cloned lines SVK-CR2/Akata c16, c12, and c7. These lines were cloned 6 months after infecting
SVK-CR2 cells with Akata strain EBV. SVK-CR2/Akata clones 12 and 16 stably express EBNA1 in around 70% of cells whilst SVK-CR2/Akata clone
7 is an EBV-negative clone derived from the same primary infection as the EBV-positive clones. (A) EBNA1 expression in SVK-CR2/Akata clone 16.
Cell smears were fixed and stained for EBNA1 by anticomplement immunofluorescence (ACIF) using a monospecific human serum, AMo. Control
uninfected SVK-CR2 cells and SVK-CR2/Akata clone 7 stained negative using the AMo antiserum and no staining was observed when the clones
were analysed using antiserum from an EBV-negative donor. (B) PCR analysis of EBNA1 mRNAs in the cloned lines. The B95.8 LCL was used as
a positive control and the uninfected SVK-CR2 cell line, SVK-CR2/Akata clone 7, and the EBV-negative Louckes BL cell line were used as negative
controls. RNA prepared from these cells was analysed by RT –PCR for EBNA1 transcription as described in the legend to Fig. 1.
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protein expression are observed (Fig. 1A) (Li et al., 1992). (Fig. 3). No signal was detected from AG876-infected
SVK-CR2 cells even after long overexposures of the auto-RNA prepared from these cells was analysed by RT –
PCR for EBNA1 transcribed from either (a) the FQp using radiographs (Fig. 3). RNA from the EBV-infected SVK-
CR2 cells was then examined for LMP2A and LMP2Ba 3* primer within the BamHI K EBNA1 ORF in combina-
tion with a 5* primer from the BamHI Q exon or (b) the transcripts by RT – PCR using a common 3* primer to
exon 3 in combination with LMP2A-specific and LMP2B-Cp/Wp using the same 3* primer in combination with a 5*
primer from the BamHI Y3 exon (Fig. 1B). These primers, specific 5* primers from the unique first exons of the two
mRNAs (Fig. 3). These primers, which have previouslywhich have previously used to examine EBNA1 transcrip-
tion in NPC and HD biopsies (Brooks et al., 1992; Deacon used to examine LMP2 transcripts in NPC and HD biops-
ies (Brooks et al., 1992; Deacon et al., 1993), yielded theet al., 1993), yielded the predicted 236-bp Q/U/K spliced
product diagnostic of FQp-driven EBNA1 transcription in predicted 280-bp LMP2A product and the predicted 324-
bp LMP2B product in Akata-infected SVK-CR2 cells againSVK-CR2 cells infected with either the Akata strain or
AG876 strain of EBV; no signal was detected in the unin- at low levels relative to the B95.8 LCL used as a positive
control; note that the B95.8 control track is underexposedfected SVK-CR2 cell line or in mock-infected SVK-neo
cells (Fig. 1B). The Q/U/K signal generated from the SVK- relative to SVK-CR2 tracks (Fig. 3). Again no signal was
detected from AG876-infected SVK-CR2 cells even afterCR2 cells infected with Akata virus was much more in-
tense than that observed with AG876 virus reflecting the long overexposures of the autoradiographs (Fig. 3).
Consistent with our original study neither EBNA2 norgenerally higher level of infection seen in these cells
with Akata strain EBV (Li et al., 1992). Thus, less than 10% LMP1 protein could be detected in SVK-CR2 at Day 5
postinfection (Li et al., 1992) using specific monoclonalof AG876-infected SVK-CR2 cells were EBNA1-positive
compared with 50% of Akata-infected SVK-CR2 cells. In antibodies in either immunostaining or immunoblotting
(data not shown) and the lack of expression of EBNA2addition the 265-bp Y3/U/K-spliced product diagnostic of
Cp/Wp-driven EBNA1 transcription could be detected at and the EBNA3 family was confirmed by immunoblotting
(see Fig. 7).trace levels in the Akata-infected SVK-CR2 cells sug-
gesting some low Cp/Wp activity in the acutely infected
epithelial cells (Fig. 1B). Note that the B95.8 LCL served EBV gene expression in cloned SVK-CR2/Akata cell
as a positive control in both assays since the majority lines
population of latently infected cells display Cp/Wp usage
and FQp is activated in the minority subpopulation which In the original studies using the SVK-CR2 system we
found that the high level of EBV infection observed imme-have entered the lytic cycle.
To confirm the low-level Cp/Wp activity in EBV-infected diately after infection was not stable but decreased such
that only 10% of the cells remained EBNA1 positive atSVK-CR2 cells, we analysed the RNA extracts using spe-
cific combinations of primers and probe capable of de- 24 days postinfection (Li et al., 1992). To generate stable
EBNA1-positive epithelial cell lines we infected the SVK-tecting either transcripts expressed from Cp leading to the
C1–C2– W1– W2 splicing pattern or transcripts expressed CR2 cell line with a single dose of Akata virus and rou-
tinely passaged the cells for 6 months. At this time, whenfrom Wp leading to the W0–W1–W2 splicing pattern (Fig.
2). As previously observed these primers give rise to the less than 2% of the cells were EBNA1 positive, the SVK-
CR2 cells were cloned by limiting dilution. Of 43 clonespredicted amplified product as well as additional higher
molecular weight species due to the presence of multiple obtained, two clones (SVK-CR2/Akata clones 12 and 16)
expressed EBNA1 and EBERs in around 70% of cells (Fig.copies of the W exons in the relevant mRNAs (Kerr et al.,
1992). Whilst transcription from both Cp and Wp was 4A) and remained EBV positive for more than 1.5 years.
An EBV-negative clone, SVK-CR2/Akata clone 7, was se-readily detectable in the B95.8 LCL, mRNAs from the Wp
promoter appeared to be much more abundant in Akata- lected for use as a negative control in subsequent analy-
ses. Analysis of EBV gene transcription using RT –PCRinfected SVK-CR2 cells than those derived from the Cp
promoter (Fig. 2). Neither Cp nor Wp transcripts were de- revealed that the stable SVK-CR2/Akata lines exclusively
utilise the FQp promoter for the transcription of EBNA1tected in the AG876-infected SVK-CR2 cells.
We next examined EBV-infected SVK-CR2 cells for the (Fig. 4B). Neither Cp nor Wp activity could be detected
by RT – PCR in the stable lines (data not shown). Tran-expression of LMP1 mRNA by RT – PCR using a 5* (2.8)
primer situated in the first exon and a 3* primer spanning scription of LMP1 and LMP2 was detected by RT– PCR
in the stable SVK-CR2/Akata lines but this was at lowthe exon 2– exon 3 boundary (Fig. 3). These primers,
which have previously used to examine LMP1 transcripts levels requiring overexposure of the autoradiograms to
be clearly observed (Fig. 5).in NPC and HD biopsies (Brooks et al., 1992; Deacon et
al., 1993), yielded the predicted 381-bp product in Akata- Neither EBNA2 nor LMP1 protein could be detected
in the stable SVK-CR2/Akata lines using specific mono-infected SVK-CR2 cells albeit at low levels relative to the
B95.8 LCL used as a positive control; note that the B95.8 clonal antibodies in either immunostaining or immu-
noblotting (data not shown) and the lack of expressioncontrol track is underexposed relative to SVK-CR2 tracks
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against EBV lytic cycle antigens as well as all the EBNAs
confirmed that acutely infected SVK-CR2 cells were able
to spontaneously enter the virus lytic cycle as evidenced
by the detection of the virus-encoded immediate early
gene product BZLF1 and early antigens (EA-D) (Fig. 7).
However, no lytic antigens were detected by immunoblot-
ting in the stable SVK-CR2/Akata lines (Fig. 7). Consistent
with our previous study, the immunoblot also confirms
that both acutely infected SVK-CR2 cells and the SVK-
CR2/Akata lines express EBNA1 but not the other EBNA
FIG. 2. Analysis of EBV latent transcripts from the Cp and Wp promot-
ers in acutely infected SVK-CR2 cells. SVK-CR2 cells infected with either
the Akata or AG876 EBV strain were harvested 5 days postinfection, a
time at which maximum levels of EBNA1 expression are observed as
previously described (Li et al., 1992). The B95.8 LCL was used as a
positive control for both Cp and Wp amplification and the uninfected
SVK-CR2 cell line, SVK-neo cells, and the EBV-negative Louckes BL
cell line were used as negative controls. RNA prepared from these
cells was analysed by RT– PCR for either (a) Cp transcripts with the
C1–C2 –W1– W2 splicing pattern using a 3* primer (b) from the W2
exon in combination with a 5* primer ( ) spanning the C1/C2
splice junction (top) or (b) Wp transcripts with W0–W1– W2 splicing
pattern using the 3* primer (b) from the W2 exon in combination with
a 5* primer ( ) spanning the W0–W1 splice junction (bottom).
Amplified products were detected by Southern blotting with an oligonu-
cleotide probe from the common W2 exon (j). Although the predicted
210-bp Wp-specific amplified product was detected, additional larger
PCR products were also seen (bottom) which are attributable to the
presence of multiple copies of the W1 and W2 exons in full-length
mRNAs; larger products were also observed using the Cp-specific prim-
ers but these were at much lower levels. The primers used in this
analysis were are previously published (Kerr et al., 1992).
of EBNA2 and the EBNA3 family was confirmed by immu-
noblotting (see Fig. 7). FIG. 3. PCR analysis of LMP mRNAs in acutely infected SVK-CR2
cells. SVK-CR2 cells infected with either the Akata or AG876 EBV strain
EBV lytic cycle in acutely versus stably infected SVK- were harvested 5 days postinfection, a time at which maximum levels
of EBNA1 expression are observed as previously described (Li et al.,CR2 cells
1992). The B95.8 LCL was used as a positive control and the uninfected
SVK-CR2 cell line, SVK-neo cells, and the EBV-negative Louckes BLWe next examined in more detail the form of EBV infec-
cell line were used as negative controls. RNA prepared from thesetion present in acutely infected SVK-CR2 cells versus
cells was analysed by RT– PCR as follows: (i) Top, LMP1 transcriptionthe stable SVK-CR2/Akata lines. Using the Gardella gel
using a 5* (2.8) primer (b) and a 3* primer ( ) spanning the exon
technique both episomal and linear forms of the EBV 2 –exon 3 splice junction. The 381-bp LMP1-specific amplified product
genome could be demonstrated in SVK-CR2 cells acutely was detected with an oligonucleotide probe from exon 2 (j); (ii) middle
and bottom, LMP2 transcription using a 3* primer (b) from the commoninfected with either Akata or AG876 virus strains (Fig. 6).
exon 3 of LMP2 in combination with a 5* primer (c) from the uniqueHowever, only the episomal form of the genome was
first exon of either LMP2A (middle) or LMP2B (bottom). The 280-bpobserved in the stable SVK-CR2/Akata lines; the epi-
LMP2A-specific and the 324-bp LMP2B-specific amplified products
somal genome load was around two copies per cell in were detected with an oligonucleotide probe from the common exon
these lines (Fig. 6, data not shown). Immunoblotting us- 2 (j). Note that the B95.8 tracks depicted were exposed for a shorter
period (2 days) than the SVK-CR2 cells (6 days).ing a polyclonal human serum containing antibodies
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ing for involucrin, one of the precursor proteins of the
cross-linked envelope (Dover and Watt, 1987). While the
parental SVK-CR2 cell line like normal skin keratinocytes
responded to differentiation induction with 10– 15% invo-
lucrin-positive cells, the SVK-CR2/Akata lines were se-
verely impaired in their ability to differentiate (Fig. 8A).
The ability of TPA to induce BZLF1 expression was exam-
ined in acutely infected SVK-CR2 cells compared to the
SVK-CR2/Akata clones. Although only around 30% of
Akata-infected SVK-CR2 cells were EBNA1-positive at 5
days postinfection, these cells spontaneously expressed
BZLF1 in 3– 5% of cells and responded well to TPA induc-
tion routinely resulting in 10– 15% BZLF1-positive cells
(Fig. 8B). However, both spontaneous and TPA-induced
BZLF1 expression were markedly impaired in the SVK-
CR2/Akata clones (Fig. 8B).
DISCUSSION
The interaction of EBV with epithelial cells is poorly
understood. Our original studies demonstrated that CR2-
transfected epithelial cell lines behave differently from B
cells with regard to the pattern of EBV gene expression
observed after infection (Li et al., 1992). Thus, EBV infec-FIG. 5. PCR analysis of LMP mRNAs in the cloned lines SVK-CR2/
tion of B cells is associated with the expression of EBERAkata c16, c12, and c7. The B95.8 LCL was used as a positive control
and the uninfected SVK-CR2 cell line and SVK-CR2/Akata c7 line were
used as negative controls. RNA prepared from these cells was ana-
lysed by RT– PCR for transcription of the LMPs as described in the
legend to Fig. 3.
proteins; the EBNA1 protein having the characteristic mo-
lecular weight of the Akata virus strain (Fig. 7).
As previously reported, acutely infected SVK-CR2 cells
can be induced to differentiate by either serum starvation
or TPA treatment and this is associated with increased
entry of the cells into the virus lytic cycle (Li et al., 1992).
The observation that the stable SVK-CR2/Akata cell lines
are unable to spontaneously enter the lytic cycle to the
same extent as acutely infected SVK-CR2 cells sug-
gested that these stable clones may be impaired in their
ability to differentiate. To investigate this further we ex-
amined the ability of the stable lines to form cross-linked
envelopes, a measure of epithelial differentiation capac-
FIG. 6. Analysis of the form of the EBV genome in acutely infected
ity, and also investigated the TPA induction of BZLF1 SVK-CR2 cells and in the stable SVK-CR2/Akata clone 16 line. DNA
expression in these lines. For this work we used sub- was extracted from Akata virus-infected SVK-CR2 cells (5 1 106 cells),
AG876 virus-infected SVK-CR2 cells (3 1 106 cells), and control Akata-clones of the SVK-CR2/Akata clone 16 cell line which
treated SVK-neo cells (5 1 106 cells) at 5 days postinfection. DNA wasstably contained 90% (cl. 16.5), 80% (cl. 16.11), and 40%
also extracted from the stable SVK-CR2/Akata clone 16 line (3 1 106(cl. 16.17) EBNA1-positive cells. These clones resembled
cells), productively infected B95.8 cells (5 1 106 cells), and uninfected
the parental SVK-CR2/Akata clone 16 cell line with re- SVK-CR2 cells (5 1 106 cells). Raji cells which support latent EBV at
spect to EBV gene expression (i.e., EBERs, FQp-driven around 50 episomal copies per cell were loaded at different cell num-
bers equivalent to 105 – 108 genomes. The Gardella gel techniqueEBNA1 transcription, low levels of LMP1 and LMP2 tran-
(Gardella et al., 1984) was used to analyze the samples and the South-scription). The ability of the SVK-CR2/Akata lines to differ-
ern blot was hybridized with a 32P-labeled BHRF1 probe. The positionsentiate was examined by maintaining the cells in suspen-
of episomal and linear forms of the EBV genome are indicated on the
sion for 24 hr, an established assay reflecting epithelial left-hand side. Note that an extra nonspecific band at a position lower
cell capacity for terminal differentiation (Adams and Watt, than that of the linear EBV genome is detected in Raji cells when
loaded at high cell numbers.1989). Differentiation induction was monitored by stain-
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this is consistent with the absence of detectable EBNA2
protein by immunoblotting (Fig. 7). However, the Wp tran-
scription observed at Day 5 postinfection could result in
FIG. 7. Immunoblot of protein extracts from SVK-neo and from SVK-
CR2 cells 5 days after exposure to Akata strain EBV, and from cloned
lines SVK-CR2/Akata clones (c) 16, 12, and 7. Control lanes contain
protein extracts from LCLs derived using Akata virus (Akata/LCL 1 and
2), from Akata BL cell line (carrying the original Akata strain virus)
induced into lytic cycle, and from an EBV-negative BL cell line, BL40.
The blot was probed with a pool of human sera containing antibodies
against all the EBNA proteins and also against components of the virus
lytic cycle.
RNAs, all six EBNA proteins (EBNAs 1, 2, 3A, 3B, 3C,
-LP) and the LMPs (LMP1, 2A, 2B) and this leads to cell
growth transformation with only the occasional trans-
formed cell entering the virus lytic cycle (Kieff and Lei-
bowitz, 1990). By contrast, infection of CR2-transfected
epithelial cell lines involves expression of the EBER
RNAs and EBNA1 and these cells can be induced into
the virus lytic cycle in a differentiation-dependent manner
(Li et al., 1992). This paper demonstrates that the tran-
scription of EBNA1 in EBV-infected epithelial cells in-
volves the same Q/U/K splice usage that is seen in group
I BL cell lines (Gregory et al., 1990), in nude mouse-
passaged NPC cell lines (Hitt et al., 1989; Brooks et al.,
1992) and in tumour biopsies of fresh NPC and EBV-
positive HD (Hitt et al., 1989; Brooks et al., 1992; Deacon FIG. 8. Analysis of epithelial differentiation and BZLF1 induction in
acutely infected SVK-CR2 cells and cloned SVK-CR2/Akata cell lines.et al., 1993); such a pattern is diagnostic of FQp usage.
(A) Ability of SVK-CR2 cells and cloned SVK-CR2/Akata cell lines toSome Cp/Wp promoter activity appears to contribute to
differentiate in suspension culture. Normal skin keratinocytes (kera-the transcription of EBNA1 in acutely infected SVK-CR2
tinos), SVK-CR2 cells, and SVK-CR2/Akata clones (cl. 16.5, cl. 16.11, cl.
cells as evidenced by the low-level detection of the Y3/ 16.17, cl. 12) were maintained in suspension for 24 hr and then exam-
U/K amplified product. This was confirmed by direct RT – ined for involucrin expression using the polyclonal rabbit antisera, DH1,
in indirect immunofluorescence (Dover and Watt, 1987). Results arePCR analysis of Cp/Wp activity which showed relatively
representative of three independent experiments and the values ob-abundant Wp activity in acutely infected SVK-CR2 cells
tained in the three separate analyses of the same cells lay within 10%and only low levels of Cp activity. Given the sensitivity
of those presented. (B) Induction of BZLF1 expression in acutely in-
of RT – PCR, the Wp transcription observed could repre- fected SVK-CR2 cells and cloned SVK-CR2/Akata cell lines. SVK-CR2
sent a minority of acutely infected epithelial cells in which cells infected with Akata virus for 5 days or the cloned SVK-CR2/Akata
lines (cl. 16.5, cl. 16.11, cl. 16.17, cl. 12) were treated with TPA (5 1EBNA1 expression is directed from Wp and in which the
1008 M) for 48 hr and the cells were examined for BZLF1 expressionfull panel of EBNAs are expressed. Whilst a few (1%)
using the BZ1 monoclonal antibody in indirect immunofluorescence.EBNA2-positive cells can only be detected by immuno-
TPA-induced BZLF1 expression at 24 hr postinduction (hatched) is com-
staining at Day 12 postinfection or later (Li et al., 1992), pared to that in uninduced cultures (solid). Results are representative
no such expression is observed at Day 5 postinfection of three independent experiments and the values obtained in the three
separate analyses of the same cells lay within 10% of those presented.when the RNA used in our analysis was harvested and
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the EBNA2 expression observed at the later time point sensitivity of protein detection or that low level LMP tran-
scription is occurring in all EBV-infected epithelial cellsor could represent low-level nonproductive Wp activity
in all infected cells. Whilst the presence of SV40 large T but does not lead to protein expression. This situation is
reminiscent of that observed in NPC biopsies where al-in the SVK-CR2 cells may affect the transcription of EBV
genes, we have observed identical patterns of EBV gene most all tumors are LMP1-positive using nested RT – PCR
irrespective of whether LMP1 is expressed at the proteinexpression and transcription in the nonvirally trans-
formed squamous cell carcinoma cell line, SCC12F, level (Brooks et al., 1992; Chen et al., 1995). We have
suggested that this discrepancy in LMP1 expression astransfected with CR2 (Li et al., 1992; Li and Young, unpub-
lished observations). Thus, our studies on acutely in- measured by nested RT– PCR versus protein expression
is probably attributable to genuine differences in the levelfected SVK-CR2 cells confirm the influence of the cellular
environment on EBV gene expression and provide a of LMP1 transcripts in different tumors; those NPC biop-
sies that have detectable LMP1 mRNA after first roundmodel for studying the factors responsible for regulating
FQp-directed EBNA1 transcription in an epithelial back- PCR amplification are also LMP1 positive at the protein
level (Brooks et al., 1992; Niedobitek et al., 1992). Never-ground.
In our original studies with SVK-CR2 cells we found theless, the overall pattern of EBV gene expression in
acutely infected SVK-CR2 cells and in the SVK-CR2/Akatathat whilst many cells became EBV-positive immediately
postinfection, a steady decline in the number of EBNA1- clones is distinct from that seen in acutely infected B
cells and more closely resembles that observed in NPCpositive cells occurred such that only around 10% of the
cells remained EBV positive at 24 days post-infection (Li biopsies.
The inability of TPA to induce BZLF1 expression in theet al., 1992). This effect seemed to correlate with the
ability of the epithelial cells to differentiate and with the SVK-CR2/Akata clones is surprising as previous studies
have shown that TPA can activate BZLF1 expressionentry of EBV-infected cells into the virus lytic cycle; the
association between epithelial differentiation and EBV through positively regulating elements in the BZLF1 pro-
moter, Zp (Flemington and Speck, 1990). However, thereplication having been previously observed both in vivo
and in vitro (Sixbey et al., 1983, 1984; Greenspan et al., control of BZLF1 transcription is complex and involves
not only Zp but also the BRLF1 promoter (Rp) which is1985; Young et al., 1991). In the present study we were
able to establish stable EBV-positive epithelial cell responsible for BZLF1 expression from a bicistronic
mRNA (Manet et al., 1989). Overall a number of positiveclones and show that these lines resemble NPC cells in
their pattern of EBV gene expression. Thus, the SVK-CR2/ and negative cellular transcription factors are responsi-
ble for regulating Zp and Rp activity (Kenney and Zalani,Akata clones display FQp-driven EBNA1 transcription, no
Wp/Cp activity and low levels of LMP expression. An 1995) and it is likely that the balance of these factors in
SVK-CR2/Akata is such that TPA induction is inhibited.extremely interesting observation is the inability of the
stable lines to differentiate and associated failure to en- Thus the selection of the SVK-CR2/Akata clones has gen-
erated cells in which EBV is unable to replicate and theter the virus productive cycle; these features are also
reminiscent of NPC (Niedobitek et al., 1992). During the fact that these clones are also impaired in their ability
to differentiate emphasises the association between EBVcloning of the stable SVK-CR2/Akata lines we were also
able to isolate EBV-negative clones (data not shown) replication and epithelial differentiation (Sixbey et al.,
1983, 1984; Greenspan et al., 1985; Young et al., 1991).which, like the EBV-positive lines, were impaired in their
ability to differentiate. This suggests that EBV infection Previous work and our own unpublished experience
suggests that the stable vector-mediated expression ofper se is not responsible for inhibiting epithelial differen-
tiation but that clonal variants in the SVK-CR2 population EBNA1 is difficult to achieve in epithelial cells perhaps
as a consequence of epithelial differentiation. Thus thewhich are unable to differentiate preferentially support
persistent EBV infection. Thus, the generation of such stable expression of EBNA1 in epithelial cells has been
reported either by transfection of EBNA1 into undifferenti-differentiation impaired clonal variants may be an im-
portant initiating event in the development of NPC fa- ated cell lines such as HeLa (Vidal et al., 1990) or by
somatic cell hybridisation of BL cell lines or fresh NPCvoring the establishment of latent EBV infection. The sub-
sequent expression of LMP1 would, as we have pre- cells with HeLa or the Ad/AH line, another undifferenti-
ated epithelial cell line (Glaser and Rapp, 1972; Takimotoviously shown (Dawson et al., 1990), further block
differentiation and thus provide a focus of undifferenti- et al., 1985). Together with the current observation that
stable infection of SVK-CR2 cells can be achieved byated epithelial cells susceptible to the accumulation of
other genetic changes. cloning out EBNA1-positive cells which are unable to
differentiate, these data suggest that stable maintenanceThe low levels of LMP1 and LMP2 mRNA detected in
the acutely infected SVK-CR2 cells and in the SVK-CR2/ of EBV in epithelial cells requires an undifferentiated cel-
lular environment. That the stable expression of EBNA1Akata clones is consistent with the inability to detect the
LMP1 at the protein level. This suggests that either very together with its function in maintaining the EBV episome
may not be sustained in the differentiated layers of stra-few cells are expressing the LMPs at levels below the
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